Health Costs
Refine Results
- view as grid
- view as list
10 FAQs on Prescription Drug Importation
These FAQs provide background on prescription drug importation, including how the U.S. currently regulates importation and why it hasn’t been successfully implemented before. These FAQs also describe the newest importation proposals, both by the Trump Administration and at the state level, how these proposals seek to address concerns with prior proposals, and how stakeholders are viewing these newest proposals
Issue Brief Read More
It May Be Time To Waive Patients’ Costs for Coronavirus Treatment
Drew Altman looks at the numbers for COVID-19 treatment, and why it may soon be necessary for Congress to waive out-of-pocket costs for treatment.
Perspective Read More
Potential Costs of Coronavirus Treatment for People with Employer Coverage
As COVID-19 spreads within the United States, questions have arisen over the potential costs people may face if they become severely ill and need treatment. While many large insurers have agreed to waive copayments and deductibles for COVID-19 tests, people with private insurance who face deductibles could still be on…
Issue Brief Read MoreNew Analysis Finds Inpatient Coronavirus Treatment Costs Could Top $20K for Patients with Employer Coverage
A new issue brief estimates potential coronavirus treatment costs to large employer health plans and their enrollees by looking at typical spending for hospital admissions for pneumonia. The analysis finds that, for pneumonia admissions with major complications and comorbidities, the average total cost is $20,292. In comparison, the average cost…
News Release Read More
Tracking the Role of Health Care in the 2020 Election: What Do The Polls Tell Us
In this post for The JAMA Forum, Larry Levitt examines both the Democratic candidates’ proposals and the Trump administration’s record on lowering drug prices, which remains a top issue for the public with bi-partisan support.
Perspective Read More
Data Note: Public Worries About And Experience With Surprise Medical Bills
This data note captures February 2020 poll findings on the public’s worries about and experiences with unexpected and surprise medical bills.
Poll Finding Read More
A Polling Surprise? Americans Rank Unexpected Medical Bills at the Top of Family Budget Worries
When it comes to family budget concerns, unexpected medical bills top Americans’ list of worries, with two-thirds (65%) of the public saying they are at least somewhat worried, including 35% who say they are “very” worried, the latest KFF Health Tracking Poll finds. Fewer Americans say they are at least…
News Release Read More
Where Do the Democratic Candidates Stand on Health Reform and Prescription Drug Prices?
Slideshow Read MoreQuestions about Prescription Drug Importation? KFF Has Answers
With lowering prescription drug costs a top priority for Americans, the Trump Administration, presidential candidates, members of Congress, and several states are proposing to allow the importation of drugs from abroad, chiefly Canada. The idea of allowing drugs to be imported from Canada and other countries is popular with Americans…
News Release Read More
Visualizing Health Policy: US Statistics on Surprise Medical Billing
This infographic examines public opinion on surprise medical billing in the United States as part of the Visualizing Health Policy infographic series, produced in partnership with the Journal of the American Medical Association (JAMA).
Infographic Read More